Interventional therapy is a new type of treatment, which is different from surgical treatment and medical treatment, and is a high-tech minimally invasive treatment between the two. The treatment method is mainly to use medical imaging equipment, with the help of puncture needles, catheters, guide wires and other equipment to enter the human body through puncture to introduce specific instruments into the human body lesions for minimally invasive treatment. Neurointervention is an important part of interventional medicine for the diagnosis and treatment of cerebrovascular. For neurointerventional therapy, it is mainly through the puncture of the femoral artery (or femoral vein, carotid artery, radial artery and other brain-related blood vessels), with the help of the digital subtraction angiography system (DSA), under X-ray fluoroscopy, through the puncture device and using Special catheters reach the neck or intracranial blood vessels to diagnose and treat lesions of the neck or intracranial blood vessels and spinal cord blood vessels.
This report contains market size and forecasts of Neurointerventional Equipment in global, including the following market information:
Global Neurointerventional Equipment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Neurointerventional Equipment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Neurointerventional Equipment companies in 2021 (%)
The global Neurointerventional Equipment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Neurothrombectomy Procedure Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neurointerventional Equipment include Stryker Corporation, Penumbra Inc., Covidien Public Limited, Johnson & Johnson Private Limited and Terumo Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neurointerventional Equipment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neurointerventional Equipment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Neurointerventional Equipment Market Segment Percentages, by Type, 2021 (%)
Neurothrombectomy Procedure
Cerebral Angiography
Stenting
Coiling Procedures
Global Neurointerventional Equipment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Neurointerventional Equipment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Research Center
Global Neurointerventional Equipment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Neurointerventional Equipment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neurointerventional Equipment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Neurointerventional Equipment revenues share in global market, 2021 (%)
Key companies Neurointerventional Equipment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Neurointerventional Equipment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Stryker Corporation
Penumbra Inc.
Covidien Public Limited
Johnson & Johnson Private Limited
Terumo Corporation